LYBE
LIVE

Serial Number

79350507

Owner

LYBE SCIENTIFIC AS

Attorney

Marcus Martinez

Filing Date

Jun 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

LYBE Trademark

Serial Number: 79350507 • Registration: 7483801

LYBE is a trademark filed by LYBE SCIENTIFIC AS on June 10, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

LYBE SCIENTIFIC AS (3 trademarks)

Krambugata 2

Entity Type: 99

Trademark Details

Filing Date

June 10, 2022

Registration Date

August 27, 2024

Published for Opposition

June 11, 2024

Goods & Services

Scientific apparatus and instruments, namely, automated liquid sample handling devices for scientific purposes used in laboratory settings in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, scientific diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, criminal investigations, food safety, metagenomics and genetics

Reagents for medical use; Medical diagnostic reagents and assays for testing body fluids, tissue or swab samples for pathogens in the form of bacteria, virus, fungi, protozoa or worms, and for genetic analyses of host cells for detection of predisposition or presence of genetic disorders or diseases; biological reagents for medical purposes; diagnostic reagents for medical purposes; pharmaceutical, medical and veterinary preparations, namely, kits comprised primarily of chemicals for sample preparation, namely, buffers, magnetic beads, enzymes obtained from body fluid, tissue and swab samples for medical purposes; chemical reagents for medical or veterinary use; clinical medical reagents; reagents for medical use, clinical medical diagnostic reagents, and medical diagnostic reagents for analysis, namely, chemical reagent solutions used in laboratory and medical testing for medical purposes and medical diagnostic purposes; enzymes, nucleotides, magnetic beads and buffers for medical diagnostic use, namely, chemical reagent solutions used in laboratory and medical testing for medical purposes; chemical reagents for medical purposes and biological analyses of tissue cultures in the form of human tissue, body fluids, organoids, animal tissue, and animal body fluids for medical purposes, cultures of pathogens in the form of bacteria, virus, fungi, protozoa or worms, and plant tissue all for medical and veterinary use

Reagents for chemical analyses for non-medical purposes; Diagnostic and molecular biology reagents for analyses of biological samples, cells, bacteria, virus, fungi, protozoa or worms other than for medical or veterinary purposes; reagents for scientific use; reagents for scientific purposes; reagents for diagnostic tests other than for medical or veterinary use; chemical reagents, other than for medical or veterinary use; Reagents and other preparations for scientific and research analysis, namely, chemical solutions for laboratory or medical research use, enzymes for scientific and research purposes, chemical preparations for scientific purposes, biological tissue cultures in the nature of human tissue, organoids of mammalian origin, human body fluids, animal tissue and animal body fluids, other than for medical or veterinary purposes, cultures of microorganisms other than for medical or veterinary use, plant tissue and nucleotides for use in science and research, none of the foregoing being for medical or veterinary use; Reagent kits for scientific and research use consisting of nucleotides, magnetic beads, reagents, enzymes, enzyme substrates, buffers, namely, chemical solutions for laboratory or medical research use, chemical preparations for scientific purposes, biological tissue cultures in the nature of human tissue, organoids of mammalian origin, human body fluids, animal tissue and animal body fluids, other than for medical or veterinary purposes, cultures of microorganisms other than for medical or veterinary use, plant tissue and enzymes all for use in science and research, not for medical or veterinary use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 13, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 12, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 27, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2024 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 18, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 28, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 28, 2024 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 6, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 16, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 15, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 27, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2023 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Oct 29, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2022 NREP
APPLICATION FILING RECEIPT MAILED
Sep 27, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 22, 2022 REPR